Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Strategies for Optimising Antenatal Corticosteroid Administration for Women With Anticipated Preterm Birth." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437626/all/Strategies_for_optimising_antenatal_corticosteroid_administration_for_women_with_anticipated_preterm_birth.
Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437626/all/Strategies_for_optimising_antenatal_corticosteroid_administration_for_women_with_anticipated_preterm_birth. Accessed January 13, 2026.
Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437626/all/Strategies_for_optimising_antenatal_corticosteroid_administration_for_women_with_anticipated_preterm_birth
Strategies for Optimising Antenatal Corticosteroid Administration for Women With Anticipated Preterm Birth [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437626/all/Strategies_for_optimising_antenatal_corticosteroid_administration_for_women_with_anticipated_preterm_birth.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth
ID - 437626
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437626/all/Strategies_for_optimising_antenatal_corticosteroid_administration_for_women_with_anticipated_preterm_birth
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

